ISOLATION OF PHAGES FOR CANDIDA INHIBITION AND INCREASING EFFICIENCY OF ANTIFUNGAL AGENTS WITH THEM

Suneeta Panicker, Samrudhi Patil, Samrudhi Peshwe, Sanika Kale

Abstract

Objectives: Most of the fungal infections are caused by Candida sp. The five prominent species of Candida which are involved in these infections are Candida albicans, Candida glabrata, Candida krusei, Candida tropicalis and Candida dublinienesis. Generally, echinocandin, ketoconazole fluconazole, amphotericin B are recommended to treat Candida infections. But, these infections are often complicated by resistance or refractoriness to current antimicrobial agents. The resistance to azole is most prominent, especially in C. albicans and C. dublinienesis. Therefore, an urgent need exists for new therapeutic strategies based on the identification of new microbial targets and novel antimicrobial agents. One such hypothetical therapeutic strategy may involve the use of mycoviruses that are able to selectively infect fungi. Methods: Candida was isolated from clinical samples. Phages against Pseudomonas were isolates and then checked the antifungal efficiency of these phages by double overlay agar method. Efficiency of these phages with the known antifungal agent (ketoconazole) was determined.Results: The phages of Pseudomonas were found to be effective against the Candida sp. Incorporation of isolated phages into antifungal agent increased its efficiency. These isolated phages can be used in various medicinal products like intimate hygiene, antifungal creams, etc. Conclusion: There are not many reports on bacterial phages against fungus pathogens hence such primitive investigations can aggravate researchers across the global to think innovatively on the similar lines and research to the molecular levels.
Keywords: Candidiasis, Biofilm, Morphology switching, Azole resistance, Pseudomonas phages, Antifungal creams.

Full Text:

PDF

References

Middleton PG, Chen SC, Meyer W (2013), Fungal infections and treatment in cystic fibrosis, Current Opinion in Pulmonary Medicine, 19(6):670-675.

Williams HD, Davies JC (2012), Basic science for the chest physician, Pseudomonas aeruginosa and the cystic fibrosis airway. Thorax, 67(5):465-467.

Preda VG, Săndulescu O (2019), Communication is the key, biofilms, quorum sensing, formation and prevention. Discoveries (Craiova, Romania), 7(3):e100.

Secor PR, Sweere JM, Michaels LA, Malkovskiy AV, Lazzareschi D, Katznelson E, Rajadas J, Birnbaum ME, Arrigoni A, Braun KR, Evanko SP, Stevens DA, Kaminsky W, Singh PK, Parks WC, Bollyky PL (2015) Filamentous Bacteriophage Promote Biofilm Assembly and Function. Cell Host & Microbe, 18(5):549–559.

Penner JC, Ferreira JAG, Secor PR, Sweere JM, Birukova MK, Joubert LM, Haagensen JAJ, Garcia O, Malkovskiy AV, Kaber G, Nazik H, Manasherob R, Spormann AM, Clemons KV, Stevens DA, Bollyky PL (2016), Pf4 bacteriophage produced by Pseudomonas aeruginosa inhibits Aspergillus fumigatus metabolism via iron sequestration. Microbiology (Reading, England), 162(9):1583-1594.

Abebe GM (2020), The role of bacterial biofilm in antibiotic resistance and food contamination. International Journal of Microbiology, 1705814.

Lin DM, Koskella B, Lin HC (2017), Phage therapy, an alternative to antibiotics in the age of multi-drug resistance. World Journal of Gastrointestinal Pharmacology and Therapeutics, 8(3):162-173.

Gileles-Hillel A, Shoseyov D, Polacheck I, Korem M, Kerem E, Cohen-Cymberknoh M (2015), Association of chronic Candida albicans respiratory infection with a more severe lung disease in patients with cystic fibrosis. Pediatric Pulmonology, 50(11):1082-1089.

Noni M, Katelari A, Kaditis A, Theochari I, Lympari I, Alexandrou-Athanassoulis H, Doudounakis SE, Dimopoulos G (2015), Candida albicans chronic colonisation in cystic fibrosis may be associated with inhaled antibiotics. Mycoses, 58(7):416-421.

Nadeem SG, Hakim ST, Kazmi SU (2010), Use of CHROM agar Candida for the presumptive identification of Candida species directly from clinical specimens in resource-limited settings. The Libyan Journal of Medicine, 5:2144, 10.3402/ljm.v5i0.2144.

Hyman P (2019), Phages for Phage Therapy, Isolation, Characterization, and Host Range Breadth. Pharmaceuticals (Basel, Switzerland), 12(1):35.

McLaughlin MR (2007), Simple colorimetric microplate test of phage lysis in Salmonella enterica. Journal of Microbiological Methods, 69(2):394-398.

Badiee P, Hashemizadeh Z (2014), Opportunistic invasive fungal infections, diagnosis & clinical management. The Indian Journal of Medical Research, 139(2):195-204.

Nazik H, Joubert LM, Secor PR, Sweere JM, Bollyky PL, Sass G, Cegelski L, Stevens DA (2017), Pseudomonas phage inhibition of Candida albicans. Microbiology (Reading, England), 163(11):1568-1577.

Refbacks

  • There are currently no refbacks.